Adverse Reactions and Interactions with H2-Receptor Antagonists
The DOI matches its Crossref record; 324 of the 326 references it cites were found in a registry or an index.
Abstract
Histamine H2-receptor antagonists have been used in the treatment of gastrointestinal diseases for more than a decade and during this period have become one of the most commonly prescribed groups of drugs in the world. The deserved popularity of the H2-receptor antagonists reflects, in part, their therapeutic efficacy, which has revolutionised the treatment of peptic ulcer disease. An equally, or more, important reason for the widespread use of H2-receptor antagonists is their remarkably low toxicity. We have attempted, in this review, to present a detailed account of the minor and more serious adverse reactions, while emphasising the low incidence of the former and the rarity of the latter. The toxicology of the H2-receptor antagonists is discussed under two main headings: adverse effects; and drug interactions. The latter category is potentially the more significant, since the frequent use of therapy with multiple drugs may give rise to drug interactions, some of which are serious and may even be lethal. These drug interactions occur especially in the gastrointestinal tract, the liver and the kidneys. Thus, the absorption of other drugs may be altered because the H2-receptor antagonists inhibit gastric secretion--an effect illustrated by ketoconazole, the absorption of which is reduced when given in combination with cimetidine. Very important drug interactions are caused by inhibition of the hepatic microsomal enzyme cytochrome P450 by some of the H2-receptor antagonists. T…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There are drug-drug interactions that can occur with H2 antihistamines through decreased gastric acidity and inhibition of P450.1192”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [1192]
Citations
Cites
Arzneimittelforschung: Erstanwendung am Menschen in der Phase I
Miletzki, B., & Gleiter, C. H. (2005) · Bundesgesundheitsblatt Gesundheitsforsch.Gesundheitsschutz · doi:10.1007/s00103-005-1024-7 · Cited by 9,355
The American Journal of Physiology
(1899) · The American Naturalist · doi:10.1086/277182 · Cited by 5,654
Drug Metabolism and Disposition
(2014) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12259_4 · Cited by 2,515
(2012) · Hepatogastroenterology · doi:10.5754/hge12183 · Cited by 1,625
NEW YORK STATE JOURNAL OF MEDICINE.
(1901) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1901.02470020041007 · Cited by 1,472
American Journal of Hospital Pharmacy
Francke, D. E. (1958) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/15.1.37 · Cited by 932
(2003) · Experimental Hematology · doi:10.1016/s0301-472x(03)00347-3 · Cited by 705
The American Journal of Gastroenterology
(2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(03)01892-6 · Cited by 649
Lebrec, D., Poynard, T., Hillon, P., & Benhamou, J.-P. (1981) · New England Journal of Medicine · doi:10.1056/nejm198112033052302 · Cited by 517
Clinical pharmacology and therapeutics
Fenn, G. C. (1990) · Postgraduate Medical Journal · doi:10.1136/pgmj.66.778.686 · Cited by 479
Research works printed but not linked: 34
- Aymard B, Aymard JP, Netter P, Legras B, Streiff F. Cytopenies sanguines associees a la prise de cimetidine. Therapie 39: 545–553, 1984
- Belaiche J, Zitoun J, Marquet J, Nurit Y, Yvart J. Effet de la ranitidine sur la secretion de facteur intrinseque gastrique et sur l’absorption de la vitamine B12. Gastroenterologie Clinique et Biologique 7: 381–384, 1983
- Bertaccini C, Coruzzi G. H2 receptor antagonists: side-effects and adverse effects. Italian Journal of Gastroenterology 16: 119–124, 1984
- Bertaccini G, Licchin L, Bonoldi C, Felder H, Debrilla G. Absence of.cholinergic-like activity of ranitidine on human salivary and lacrimal secretions. Italian Journal of Gastroenterology 13: 253–254, 1981
- Bianchi Porro G, Cheli R. Gynaecomastia and ranitidine. Italian Journal of Gastroenterology 16: 56, 1984
- Bianchi Porro G, Petrillo M, Recchia G. The safety of ranitidine: 1981–83 post-marketing surveillance experience in Italy. Clinical Trials Journal 22: 441–447, 1985a
- Braito E, Oberlechner R, Camberlato R, Amplatz S, Dobrilla G. Heart rate and blood pressure in non-cardiopathic volunteers receiving acute intravenous loads of H2-antagonists. Trial based on Holter-Edwards dynamic electrocardiography. Italian Journal of Gastroenterology 17: 176, 1985
- Buchanan KD, Spencer A, Ardill J, Kennedy TL. Hypergastrinaemia due to cimetidine. Gut 19: A437, 1978
- Cavallini G, Angelini G, Vaona B, Bovo P, Rosa B, et al. Ranitidine and Candida albicans. Italian Journal of Gastroenterology 15: 189, 1983
- Dabadie H, Lamouliatte H, Quinton A, Geniaux M. Syndrome de Lyell induit par la cimetidine. Gastroenterologie Clinique et Biologique 7: 425–426, 1983
- Dobrilla G, Coruzzi G, Bertaccini G, Carvallini G. Extragastric effect of ranitidine. Italian Journal of Gastroenterology 14: 55–56, 1982
- Dorr RT. Effects of H2 antagonists on highly-metabolized anti-cancer drugs. Gastroenterology 88: 1368, 1985
- Enzmann GD, Leonard JM, Paulsen CA, Rogers J. Effect of cimetidine on reproductive function in men. Clinical Research 29: 26A, 1981
- Hadas N, Wapnick S, Grosberg SJ, Sugaar S. Cimetidine induced mortality in experimental pancreatitis. Gastroenterology 76: 1148, 1979
- Hagenmüller F, Usadel KH, Schwedes U, Zeitler-Abu-Ishira A, Classen M. Ranitidin und Cimetidin: Untersuchungen Zur Gastralen Sekretionshemmung und Antiandrogenität. Innere Medizin 9: 347–352, 1982
- Hansen WE, Nehammer K. Inhibition of cholinesterases by oxmetidine. Gastroenterology 86: 1107, 1984
- Hayakawa A, Che K, Miyoshi A, Harawara S, Miwa T, et al. Properties of famotidine in relation to safety. Italian Journal of Gastroenterology 16: 174–176, 1984
- Hine KR, Holmes GKT, Milnes JP, Phillips A, Poynter D, et al. Microscopic examination of gastric biopsies from patients treated with ranitidine. Gastroenterology 82: 1085, 1982
- Leslie GB, Walker TF. A toxicological profile of cimetidine. In Burland WL & Simkins MA (Eds). Cimetidine — proceedings of the second international symposium on histamine H2 receptor antagonists, pp. 24–33, Excerpta Medica, Amsterdam, 1977
- Lombardo L. Hyperprolactinaemia: ranitidine revisited adverse effect. Italian Journal of Gastroenterology 17: 160, 1985
- McGonigle RJS, Williams LC, Amphlett GE, England RJ, Parsons V. The pharmacokinetics of ranitidine in renal disease. In Misiewicz JJ & Wormsley KG (Eds). The clinical use of ranitidine, pp. 41–46, Medicine Publishing Foundation, Oxford 1982
- Mantero F. Ranitidine and gynaecomastia. Italian Journal of Gastroenterology 17: 114, 1985
- Mavier P, Preaux AM, Delchier JC, Beauchant M, Dhumeaux D. Comparaison des effets de la cimetidine et de la ranitidine in vivo et in vitro sur le systeme enzymtique microsomal hepatique chez le rat. Gastroenterologie Clinique et Biologique 7: 244–250, 1983
- Miyoshi A, Muto V, Mori H, Miwa T, Nakazawa S, et al. Famotidine: summary of overall safety from Japanese clinical studies. Italian Journal of Gastroenterology 16: 177–178, 1984
- Pallone F, Paoluzi P, Marcheggiano A, Ripoli F, Carratu R. Cimetidine and duodenal ulcer associated gastritis. Italian Journal of Gastroenterology 12: 210–211, 1980
- Paradelis AG, Triantaphyllidis CJ, Stavrakis AO, Crassaris LG. Interaction of aminoglycoside antibiotics with H2-receptor blocking agents at the neuromuscular junctions. Drugs in Experimental and Clinical Research 10: 807–811, 1984
- Pasquali R, Corinaldesi R, Patrono D, Capelli M, Stanghellini V, et al. Effect ot intravenous ranitidine on serum prolactin (PRL): evidence for a sex difference. Gastroenterology 84: 1271, 1983
- Peden NR, Wormsley KG. Alleged impotence with ranitidine. Lancet 2: 798, 1983
- Simon B, Müller P, Dammann HG. Safety profile of ranitidine. In Riley AJ & Salmon PR (Eds). Ranitidine, pp 181–189, Excerpta Medica, Amsterdam, 1982
- Simon B, Müller P, Dammann HG. Cimetidine, Ranitidin und Famotidin: eine vergleichende Wertung. Innere Medizin 11: 81–84, 1984
- Tomioka K, Yamada T, Tachikawa S. Effects of famotidine (YM11170), an H2-receptor antagonist, on in vivo immediate and delayed type hypersensitivity reactions and antibody formation. Drugs under Experimental and Clinical Research 9: 881–889, 1983
- Vickers MR, Arlington SA, Jones C, Martin D, Melvin MA. The role of histamine in immune responses. In Torsoli A, Lucchelli PE, Brimblecombe RW (Eds). Further experience with H2-receptor antagonists in peptic ulcer disease and progress in histamine research, pp 311–326, Excerpta Medica, Amsterdam, 1980
- Willing RL, Whitehead R, Oldmeadow M, Mackinnon M. Cimetidine and duodenitis — a placebo controlled double blinded study of the effect of cimetidine on the endoscopic and histological appearances of duodenitic mucosa. Gastroenterology 78: 1291, 1980
- Wilson JA, Craig IF. Cimetidine, ranitidine and HDL-cholesterol. Gastroenterology 88: 1632, 1985
Cited by
International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
Wise, S. K., Lin, S. Y., Toskala, E., Orlandi, R. R., Akdis, C. A., Alt, J. A., Azar, A., Baroody, F. M., Bachert, C., Canonica, G. W., et al. (2018) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22073 · Cited by 557
International consensus statement on allergy and rhinology: Allergic rhinitis – 2023
Wise, S. K., Damask, C., Roland, L. T., Ebert, C., Levy, J. M., Lin, S., Luong, A., Rodriguez, K., Sedaghat, A. R., Toskala, E., et al. (2023) · International Forum of Allergy & Rhinology · doi:10.1002/alr.23090 · Cited by 507
Peptic Ulcer Disease: A Brief Review of Conventional Therapy and Herbal Treatment Options
Kuna, L., Jakab, J., Smolic, R., Raguz-Lucic, N., Vcev, A., & Smolic, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8020179 · Cited by 349
Lancaster-Smith, M., Jaderberg, M. E., & Jackson, D. A. (1991) · Gut · doi:10.1136/gut.32.3.252 · Cited by 144
Pharmacokinetic Drug Interactions with Antimicrobial Agents
Gillum, J. G., Israel, D. S., & Polk, R. E. (1993) · Clinical Pharmacokinetics · doi:10.2165/00003088-199325060-00005 · Cited by 143
Metadata
- Authors
- Pension, J., & Wormsley, K. G.
- Affiliations
- University of Dundee (GB)
- Venue
- Medical Toxicology
- Published
- 1986-06
- Volume
- 1
- Issue
- 3
- Pages
- 192-216
- ISSN
- 0112-5966 (ISSN-L)
- OpenAlex
- W2465608970
- Cited by
- 63
- References
- 326
- Citations by year
- 2024: 2 · 2023: 1 · 2022: 3 · 2021: 2 · 2020: 2 · 2019: 1 · 2018: 2 · 2017: 1 · 2016: 1 · 2014: 1 · 2013: 2 · 2012: 2
- FWCI
- 4.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Medical Toxicology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Keywords
- H2 receptor antagonists, adverse drug reactions, drug interactions, cimetidine, ranitidine, ketoconazole, cytochrome P450 inhibition, drug metabolism, gastric acid secretion, drug absorption, renal tubular secretion, procainamide, quinidine, peptic ulcer, drug toxicity, gastrointestinal adverse effects, renal adverse effects
- MeSH terms
- Animals, Cardiovascular Diseases, Central Nervous System Diseases, Digestive System Diseases, Drug Interactions, Endocrine System Diseases, Hematologic Diseases, Histamine H2 Antagonists, Humans, Kidney Diseases, Skin Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Adverse Reactions and Interactions with H2-Receptor Antagonists. https://app.cochat.ai/papers/10.1007/bf03259837
- The paper
- Pension, J., & Wormsley, K. G. (1986). Adverse Reactions and Interactions with H2-Receptor Antagonists. Medical Toxicology. https://doi.org/10.1007/bf03259837
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.